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Persistence of Neointimal Growth 12 Months After Intervention and Occurrence
of Delayed Restenosis in Patients With Left Main Coronary Artery Disease
Treated With Drug-Eluting Stents
To the Editor: Although long-term follow-up after drug-eluting
stent (DES) implantation shows a sustained clinical benefit in
several registries and randomized trials (1), little is known about
the pattern of neointimal growth beyond the first six to nine
months. In particular, when exactly neointima growth after DES
implantation begins to subside remains largely unknown.
The mechanism of action of DES on neointimal proliferation
seems to be partially explained by a delay in vascular response,
which has supported the concern that late restenosis (i.e., occurring
beyond six months) might occur in humans (2).
This would be of clinical relevance especially for patients
receiving DES implantation for the treatment of left main coro-
nary artery (LMCA) disease, in whom restenosis is considered a
major, and potentially fatal, complication after percutaneous in-
tervention.
Up to March 6, 2004, a total of 110 consecutive patients were
treated exclusively with one or more DES in the LMCA as part of
an elective or non-elective revascularization procedure at our
institution. Seventy-three patients received 6-month angiographic
follow-up, of whom 15 underwent paired angiographic measures at
12 months, which was not preceded by target vessel reintervention,
and constitute the patient population of the present report.
Quantitative angiographic analyses were performed with the use
of edge-detection techniques (CAAS II, Pie Medical, Maastricht,
the Netherlands). Binary restenosis was defined as stenosis of more
than 50% of the luminal diameter in the target lesion. Late loss was
defined as the minimal lumen diameter (MLD) immediately after
the index procedure minus the MLD at angiographic follow-up.
Continuous variables are shown as median and interquartile
range and were compared using Wilcoxon test or a general liner
mixed model followed by post-hoc analysis after log transforma-
tion for normalization. Probability was significant at a level of
0.05.
The characteristics of the study population (Table 1) did not
differ with respect to the patients receiving no or six-month
angiographic follow-up only.
The reason for repeating a second coronary angiogram included
risk-stratification before non-cardiac major surgery in three (Pa-
tients #1, #6, and #14), evidence of inducible ischemia at nonin-
vasive stress test in two (Patients #4 and #15), a staged procedure
for the treatment of the right coronary artery in one (Patient #13),
and the willingness to repeat a second coronary angiogram in the
remaining nine after counselling about the potential consequence
of in-stent restenosis at the time of the index procedure. No major
adverse cardiovascular event previously occurred in this cohort of
patients, and all except one were asymptomatic at the time of
repeated catheterization.
Quantitative coronary analysis on paired measurements in the
main treated branch (i.e., LMCA or LMCA and the proximal
tract of the left anterior descending artery) is shown in Table 1.
When all intervened coronary segments were cumulatively consid-
ered (n  20), including the stented proximal tract of the
circumflex artery in five patients receiving bifurcation stenting, the
MLD decreased from 2.78 (2.49 to 2.95) after the procedure to
2.44 mm (2.07 to 3.09) (p  0.37) and 2.25 (1.85 to 2.70) (p 
0.005 vs. post-procedure and p  0.054 vs. 6-month) at 6 and 12
months, respectively. The late loss (mm) increased from 0.29 (0.07
to 0.4) at 6 months to 0.63 (0.37 to 0.76) after 12 months (p 
0.001) (Fig. 1). Cumulatively, Patient #13, presenting with mild
intimal hyperplasia at 6 months, received a target vessel revascu-
larization at 12 months due to severe focal in-stent restenosis in the
mid-shaft of the LMCA (Fig. 1C), while a focal restenosis in the
ostium of the circumflex artery detected at 12-month follow-up in
Patient #2 was left untreated due to normal coronary reserve at
non-invasive nuclear stress imaging.
Previous serial angiographic analyses showed that intimal hyper-
plasia peaks after 12 to 16 weeks after intervention and that restenosis
rarely occurs beyond 3 months after bare metal stent implantation (3).
These observations justify current practice to perform angiographic
follow-up six to eight months after percutaneous coronary revascular-
ization, when the intimal growth has ceased and the net lumen gain
is likely to be maintained over time. Indeed, a partial regression of the
in-stent intimal hyperplasia at longer-term follow-up in patients
receiving bare metal stents has been reported (3).
When exactly neointima growth after DES implantation begins
to subside remains largely unknown, but based on experimental
findings, a late catch up phenomenon has been hypothesized (2). Of
some concern is the fact that similar argumentations have been
previously raised after intravascular brachytherapy, based on find-
ings on animals, which were subsequently confirmed in humans
(4). In the longest available angiographic follow-up after DES
implantation, neointimal growth has been shown to mildly non-
significantly progress beyond one year (1). Whether this would
result in delayed restenosis remained unclear.
In our small series of patients undergoing serial angiographic
monitoring, a significant increase of late loss between 6 and 12
months was noted, and, more importantly, one patient devel-
oped late in-stent restenosis of the LMCA, which necessitated
reintervention.
Our preliminary findings raise several unanswered questions.
This study was not pre-specified, as it was urged by the one-year
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Table 1. Baseline and Procedural Characteristics and Serial Quantitative Coronary Analysis of the Main Treated Branch
Patient No.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Age, yrs 68 69 64 63 48 46 70 30 50 72 70 72 78 56 64
Gender M M M M M M F M F M F M M M F
Diabetes No Yes No No No No No No No No Yes No Yes No No
Creatinine (mol/l) 79 69 85 90 94 98 53 68 68 73 61 70 92 187 254
Protected LMCA No No No No Yes No No No No No Yes No No No No
Clinical presentation STEMI SA SA SA SA SA STEMI SA UA III B UA II B SA UA III A SA UA III B UA II B
Parsonnet score 19.5 12 6.5 3.5 9 6.5 19.5 25.5 19 2.5 19 2.5 14 18 21
Lesion location Mid Distal Distal Ostial Ostial Mid Distal Distal Mid Mid Distal Mid Distal Ostial Distal
Severe calcification No No No No Yes No No No No No No Yes No No Yes
Stent type SES SES SES SES SES SES SES SES SES SES PES PES PES PES PES
Stent no. 1 2 1 1 1 1 1 2 1 2 2 2 2 1 2
Total stent length, mm 18 51 18 8 18 33 18 26 33 16 36 16 40 32 28
Bifurcation stenting No Yes No No No No No Yes No No Yes No Yes No Yes
Technique — T-stent — — — — — Crush — — Culotte — Culotte — V-stent
Post-dilation Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes No Yes
Final kissing No No No Yes No No No No No No No No Yes No Yes
QCA post-PCI
RVD (mm) 3.95 3.05 3.40 2.61 3.42 3.58 3.68 2.89 3.16 3.43 2.42 3.40 2.70 3.53 2.89
MLD (mm) 3.57 3.04 2.77 2.56 3.41 2.91 3.60 2.89 2.49 3.11 2.43 2.95 2.26 3.51 2.71
Vessel stenosis (%) 10 0 18 2 0 19 2 0 21 9 0 13 16 6 6
QCA at 6-month follow-up
RVD (mm) 3.89 3.12 3.9 2.67 3.52 3.38 3.53 3.04 2.67 3.59 2.45 3.93 2.24 3.59 2.61
MLD (mm) 3.51 3.04 3.09 2.49 3.21 3.28 2.99 1.96 2.07 3.33 2.01 3.64 1.86 3.11 2.27
Vessel stenosis (%) 10 3 21 7 9 3 15 35 22 7 18 7 17 13 13
QCA at 12-month follow-up
RVD (mm) 3.79 2.74 3.45 2.50 3.20 3.44 3.12 3.12 2.66 3.26 2.55 3.37 3.17 3.78 2.58
MLD (mm) 2.84 2.70 2.40 2.37 2.18 3.12 2.87 1.92 1.95 2.99 1.62 2.81 1.03 3.01 2.27
Vessel stenosis (%) 25 1 29 5 31 9 8 38 27 8 36 17 81 20 12
LMCA  left main coronary artery; MLD  minimal lumen diameter; PCI  percutaneous coronary intervention; PES  paclitaxel-eluting stent; QCA  quantitative coronary analysis; RVD  reference vessel diameter; SA  stable
angina; SES  sirolimus-eluting stent; STEMI  ST-segment elevation myocardial infarction; UA  unstable angina followed by Braunwald classification.
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findings on Patient #13. Importantly, the increase in late loss from
6 to 12 months turned out to be a consistent observation also in
other LMCA-intervened patients, triggering the present report. It
remains unclear based on our data whether intima hyperplasia
peaks at 12 months or even later after DES LMCA stenting.
Whether our results are applicable also to non-left main lesions is
currently unknown.
Recently, Wessely et al. (5) reported on two patients treated
with sirolimus-eluting stent in the left anterior descending artery
and right coronary artery who presented at 13 and 19 months,
respectively, with recurrence of symptoms and angiographically
confirmed in-stent restenosis. Of note, both patients had under-
gone previous coronary angiogram at seven months, which showed
no evidence of intima growth at that stage.
The finding that intima growth may persist well beyond the
conventional six to eight months after intervention may cast a
shadow of doubt on current attempts to employ power transfor-
mation of late loss at six to eight months to predict long-term stent
performance.
The clinical implications of the delayed occurrence of in-stent
restenosis after DES in patients undergoing intervention for
LMCA disease remain unclear.
A prolonged clinical and angiographic surveillance in this subset
of patients seems to be warranted.
Figure 1. Change of minimal lumen diameter (MLD) (A) and lumen diameter stenosis (B) as a consequence of treatment in 20 intervened coronary segments,
including the LMCA (and the proximal tract of the left anterior descending artery if stented) in 15 patients and the proximal segment of the circumflex artery in
5 patients who received bifurcation stenting. (A) At 12 months, the MLD (mm) reduced significantly compared to post-intervention (p  0.001) and tended to
be smaller than that noted at 6 months (p 0.054). The late loss passed from 0.29 (0.07 to 0.4) at 6 months to 0.63 (0.37 to 0.76) after 12 months (p 0.001).
p 0.001 vs. late loss recorded at six months. (B) The vessel diameter stenosis (%) passed from 54 (50 to 60) before to 7 (2 to 10) after the procedure (p 0.001),
to 14 (9 to 18) at 6 months (p 0.3 vs. post-procedure) and to 28 (17 to 35) at 12 months (p 0.066 vs. 6 months). PCI percutaneous coronary intervention.
Continued on next page.
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Figure 1 Continued. (C) Sequential coronary angiographies showing the left main coronary artery (magnified at the right) and the proximal and mid-tract
of circumflex and anterior descending arteries of Patient #13. Panel I: A stenosed distal left main coronary artery with its magnification in the right quadrant
and a suboccluded circumflex artery are visible before treatment. Panel II: Angiographic result immediately after treatment. At six months (panel III), a
moderate focal restenosis in the proximal tract of the left main coronary artery was present (arrowhead) that did not cause significant obstruction of the
lumen at intravascular ultrasound (IVUS) investigation (lower panel) and did not result to be flow-limiting, with a fractional flow reserve of 0.85. At 12
months (panel IV), control angiogram revealed a tight in-stent restenosis (arrowhead), magnified in the insert, through which the IVUS probe could not
be negotiated and required reintervention. Lower panel is showing four IVUS cross-sections (Atlantis 40 Mhz, Boston Scientific, Natick, Massachusetts)
from the left main coronary artery at six months: (a) proximal edge of the stent in the left main coronary artery, with a malapposed strut visible at 7 o’clock;
(b) in-stent concentric growth of intimal hyperplasia at the minimal lumen area; (c) minor degree of in-stent eccentric hyperplasia located in the mid-tract
of the left main coronary artery at 9 o’clock; (d) left main coronary artery carina, showing no sign of intimal hyperplasia, with the stented circumflex artery
originating at 11 o’clock.
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